334 related articles for article (PubMed ID: 18832653)
1. NKT-cell help to B lymphocytes can occur independently of cognate interaction.
Tonti E; Galli G; Malzone C; Abrignani S; Casorati G; Dellabona P
Blood; 2009 Jan; 113(2):370-6. PubMed ID: 18832653
[TBL] [Abstract][Full Text] [Related]
2. Follicular helper NKT cells induce limited B cell responses and germinal center formation in the absence of CD4(+) T cell help.
Tonti E; Fedeli M; Napolitano A; Iannacone M; von Andrian UH; Guidotti LG; Abrignani S; Casorati G; Dellabona P
J Immunol; 2012 Apr; 188(7):3217-22. PubMed ID: 22379027
[TBL] [Abstract][Full Text] [Related]
3. Invariant NKT cells facilitate cytotoxic T-cell activation via direct recognition of CD1d on T cells.
Qin Y; Oh S; Lim S; Shin JH; Yoon MS; Park SH
Exp Mol Med; 2019 Oct; 51(10):1-9. PubMed ID: 31653827
[TBL] [Abstract][Full Text] [Related]
4. NK T cells provide lipid antigen-specific cognate help for B cells.
Leadbetter EA; Brigl M; Illarionov P; Cohen N; Luteran MC; Pillai S; Besra GS; Brenner MB
Proc Natl Acad Sci U S A; 2008 Jun; 105(24):8339-44. PubMed ID: 18550809
[TBL] [Abstract][Full Text] [Related]
5. Coordination between T helper cells, iNKT cells, and their follicular helper subsets in the humoral immune response against Clostridium difficile toxin B.
Rampuria P; Lang GA; Devera TS; Gilmore C; Ballard JD; Lang ML
J Leukoc Biol; 2017 Feb; 101(2):567-576. PubMed ID: 27566831
[TBL] [Abstract][Full Text] [Related]
6. CD40L-null NKT cells provide B cell help for specific antibody responses.
Shah HB; Joshi SK; Lang ML
Vaccine; 2011 Nov; 29(49):9132-6. PubMed ID: 21959330
[TBL] [Abstract][Full Text] [Related]
7. BAFF- and APRIL-dependent maintenance of antibody titers after immunization with T-dependent antigen and CD1d-binding ligand.
Shah HB; Joshi SK; Rampuria P; Devera TS; Lang GA; Stohl W; Lang ML
J Immunol; 2013 Aug; 191(3):1154-63. PubMed ID: 23797666
[TBL] [Abstract][Full Text] [Related]
8. Reduction of CD1d expression in vivo minimally affects NKT-enhanced antibody production but boosts B-cell memory.
Lang GA; Johnson AM; Devera TS; Joshi SK; Lang ML
Int Immunol; 2011 Apr; 23(4):251-60. PubMed ID: 21398691
[TBL] [Abstract][Full Text] [Related]
9. The mechanism of splenic invariant NKT cell activation dictates localization in vivo.
King IL; Amiel E; Tighe M; Mohrs K; Veerapen N; Besra G; Mohrs M; Leadbetter EA
J Immunol; 2013 Jul; 191(2):572-82. PubMed ID: 23785119
[TBL] [Abstract][Full Text] [Related]
10. Identification of distinct human invariant natural killer T-cell response phenotypes to alpha-galactosylceramide.
Croudace JE; Curbishley SM; Mura M; Willcox CR; Illarionov PA; Besra GS; Adams DH; Lammas DA
BMC Immunol; 2008 Dec; 9():71. PubMed ID: 19055753
[TBL] [Abstract][Full Text] [Related]
11. CD1d-independent activation of mouse and human iNKT cells by bacterial superantigens.
Hayworth JL; Mazzuca DM; Maleki Vareki S; Welch I; McCormick JK; Haeryfar SM
Immunol Cell Biol; 2012 Aug; 90(7):699-709. PubMed ID: 22041925
[TBL] [Abstract][Full Text] [Related]
12. The CD1d-binding glycolipid alpha-galactosylceramide enhances humoral immunity to T-dependent and T-independent antigen in a CD1d-dependent manner.
Lang GA; Exley MA; Lang ML
Immunology; 2006 Sep; 119(1):116-25. PubMed ID: 16792697
[TBL] [Abstract][Full Text] [Related]
13. Combined proinflammatory cytokine and cognate activation of invariant natural killer T cells enhances anti-DNA antibody responses.
Sedimbi SK; Hägglöf T; Garimella MG; Wang S; Duhlin A; Coelho A; Ingelshed K; Mondoc E; Malin SG; Holmdahl R; Lane DP; Leadbetter EA; Karlsson MCI
Proc Natl Acad Sci U S A; 2020 Apr; 117(16):9054-9063. PubMed ID: 32295878
[TBL] [Abstract][Full Text] [Related]
14. Vaccine Designs Utilizing Invariant NKT-Licensed Antigen-Presenting Cells Provide NKT or T Cell Help for B Cell Responses.
Fujii SI; Yamasaki S; Sato Y; Shimizu K
Front Immunol; 2018; 9():1267. PubMed ID: 29915600
[TBL] [Abstract][Full Text] [Related]
15. Scavenger receptors target glycolipids for natural killer T cell activation.
Freigang S; Landais E; Zadorozhny V; Kain L; Yoshida K; Liu Y; Deng S; Palinski W; Savage PB; Bendelac A; Teyton L
J Clin Invest; 2012 Nov; 122(11):3943-54. PubMed ID: 23064364
[TBL] [Abstract][Full Text] [Related]
16. Invariant natural killer T cells: innate-like T cells with potent immunomodulatory activities.
Wu L; Gabriel CL; Parekh VV; Van Kaer L
Tissue Antigens; 2009 Jun; 73(6):535-45. PubMed ID: 19392798
[TBL] [Abstract][Full Text] [Related]
17. CD1d-dependent immune suppression mediated by regulatory B cells through modulations of iNKT cells.
Oleinika K; Rosser EC; Matei DE; Nistala K; Bosma A; Drozdov I; Mauri C
Nat Commun; 2018 Feb; 9(1):684. PubMed ID: 29449556
[TBL] [Abstract][Full Text] [Related]
18. NKT cells enhance CD4+ and CD8+ T cell responses to soluble antigen in vivo through direct interaction with dendritic cells.
Hermans IF; Silk JD; Gileadi U; Salio M; Mathew B; Ritter G; Schmidt R; Harris AL; Old L; Cerundolo V
J Immunol; 2003 Nov; 171(10):5140-7. PubMed ID: 14607913
[TBL] [Abstract][Full Text] [Related]
19. Dendritic cell internalization of α-galactosylceramide from CD8 T cells induces potent antitumor CD8 T-cell responses.
Choi DH; Kim KS; Yang SH; Chung DH; Song B; Sprent J; Cho JH; Sung YC
Cancer Res; 2011 Dec; 71(24):7442-51. PubMed ID: 22028323
[TBL] [Abstract][Full Text] [Related]
20. Retinoic acid and α-galactosylceramide differentially regulate B cell activation in vitro and augment antibody production in vivo.
Chen Q; Mosovsky KL; Ross AC
Clin Vaccine Immunol; 2011 Jun; 18(6):1015-20. PubMed ID: 21471300
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
